Want to track AKBA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Akebia Therapeutics Inc. (AKBA) Statistics
Valuation metrics
Market Cap 375.56M
Enterprise value 209.32M
Trailing P/E (ttm) -17.38
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 1.55
Price/Book (mrq) 13.07
Enterprise Value/Revenue 0.9
Enterprise Value/EBITDA -36.34
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.52M
Average volume (90 days) 4.51M
Price summary
52-Week low 0.82
52-Week high 4.04
Beta -
50-Day moving average 1.05
200-Day moving average 1.31
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.09%
Operating margin 0.02%
Operational effectiveness
Return on assets -0.06%
Return on equity -0.63%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.87
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.61
Total debt (mrq) -
Total Debt/Equity (mrq) 0.46
Current ratio (mrq) 1.4%
Book value per share (mrq) 0.1
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
